Endocrine Connections (Nov 2017)

Tumour diameter is not reliable for management of non-secreting pancreatic neuroendocrine tumours

  • Logan Mills,
  • Panagiotis Drymousis,
  • Yogesh Vashist,
  • Christoph Burdelski,
  • Andreas Prachalias,
  • Parthi Srinivasan,
  • Krishna Menon,
  • Corina Cotoi,
  • Saboor Khan,
  • Judith Cave,
  • Thomas Armstrong,
  • Martin O Weickert ,
  • Jakob Izbicki,
  • Joerg Schrader,
  • Andreja Frilling,
  • John K Ramage,
  • Raj Srirajaskanthan

DOI
https://doi.org/10.1530/EC-17-0293
Journal volume & issue
Vol. 6, no. 8
pp. 876 – 885

Abstract

Read online

Small non-functioning pancreatic NETs (pNETs) ≤2 cm can pose a management dilemma in terms of surveillance or resection. There is evidence to suggest that a surveillance approach can be considered since there are no significant radiological changes observed in lesions during long-term follow-up. However, other studies have suggested loco-regional spread can be present in ≤2 cm pNETs. The aim of this study was to characterise the prevalence of malignant features and identify any useful predictive variables in a surgically resected cohort of pNETs. 418 patients with pNETs were identified from 5 NET centres. Of these 227 were included for main analysis of tumour characteristics. Mean age of patients was 57 years, 47% were female. The median follow-up was 48.2 months. Malignant features were identified in 38% of ≤2 cm pNETs. ROC analysis showed that the current cut-off of 20 mm had a sensitivity of 84% for malignancy. The rate of malignant features is in keeping with other surgical series and challenges the belief that small pNETs have a low malignant potential. This study does not support a 20 mm size cut-off as being a solitary safe parameter to exclude malignancy in pNETs.

Keywords